Correlation Between Maccura Biotechnology and Shanghai Rongtai

Can any of the company-specific risk be diversified away by investing in both Maccura Biotechnology and Shanghai Rongtai at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maccura Biotechnology and Shanghai Rongtai into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maccura Biotechnology Co and Shanghai Rongtai Health, you can compare the effects of market volatilities on Maccura Biotechnology and Shanghai Rongtai and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maccura Biotechnology with a short position of Shanghai Rongtai. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maccura Biotechnology and Shanghai Rongtai.

Diversification Opportunities for Maccura Biotechnology and Shanghai Rongtai

0.36

Correlation Coefficient

Maccura Biotechnology  Shanghai Rongtai

Weak diversification

The 3 months correlation between Maccura and Shanghai is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Maccura Biotechnology Co and Shanghai Rongtai Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rongtai Health and Maccura Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maccura Biotechnology Co are associated (or correlated) with Shanghai Rongtai. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rongtai Health has no effect on the direction of Maccura Biotechnology i.e., Maccura Biotechnology and Shanghai Rongtai go up and down completely randomly.

Pair Corralation between Maccura Biotechnology and Shanghai Rongtai

Assuming the 90 days trading horizon Maccura Biotechnology Co is expected to under-perform the Shanghai Rongtai. But the stock apears to be less risky and, when comparing its historical volatility, Maccura Biotechnology Co is 1.79 times less risky than Shanghai Rongtai. The stock trades about -0.11 of its potential returns per unit of risk. The Shanghai Rongtai Health is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,534  in Shanghai Rongtai Health on December 1, 2024 and sell it today you would earn a total of  117.00  from holding Shanghai Rongtai Health or generate 7.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Maccura Biotechnology Co  vs.  Shanghai Rongtai Health

Maccura Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Shanghai Rongtai Health

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Maccura Biotechnology and Shanghai Rongtai

The main advantage of trading using opposite Maccura Biotechnology and Shanghai Rongtai positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maccura Biotechnology position performs unexpectedly, Shanghai Rongtai can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rongtai will offset losses from the drop in Shanghai Rongtai's long position.

The idea behind Maccura Biotechnology Co and Shanghai Rongtai Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..